As the pace of technology alters the complex landscape of healthcare, expert legal and regulatory guidance are as critical as ever. Goodwin’s industry-leading team of nearly 200 lawyers focused on healthcare, including the convergence of traditional healthcare services with cutting-edge technologies including artificial intelligence and digital therapeutics, brings a breadth and depth of expertise and practical insight to help clients achieve their goals. And with our robust private equity, life sciences and technology practices, we frequently connect innovators with investors, and represent healthcare developers from inception to exit and all points in between.

Goodwin’s healthcare team covers the full spectrum. We counsel healthcare service providers, life sciences and digital health companies, and investors on transactions and on applicable healthcare and FDA laws and regulations. We also have a long track record of successfully defending clients in investigations related to fraud and abuse and qui tam litigation. We understand the regulatory environment from a variety of perspectives which enables us to navigate its complexity and provide practical solutions to clients. Our experience spans all aspects of healthcare law including: Anti-Kickback Statute, Stark Law, False Claims Act, fraud and abuse regulations, corporate practice of medicine laws, Medicare and Medicaid rules and regulation, HIPAA, data privacy and security, HITECH Act, and a growing number of state laws concerning privacy and security of health information. Additionally, our team brings expertise on the FDA regulatory aspects of healthcare, including counseling on developmental and market pathways for innovative digital health tools, therapeutics, and diagnostics, along with counseling on regulatory issues that arise in the healthcare setting where FDA-regulated products are utilized and administered.

Recent Highlights